Jun-Ho Cho

发表

Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.

J. Chou, Jun-Ho Cho, Young Mok Lee, 2019, Biochemical and biophysical research communications.

Inhibition of Apoptosis Signal-regulating Kinase 1 by Nitric Oxide through a Thiol Redox Mechanism*

Mi-Sung Kim, E. Choi, S. Huh, 2004, Journal of Biological Chemistry.

CIIA functions as a molecular switch for the Rac1-specific GEF activity of SOS1

Ssang-Goo Cho, E. Choi, Jun-Ho Cho, 2011, The Journal of cell biology.

Negative regulation of SEK1 signaling by serum‐ and glucocorticoid‐inducible protein kinase 1

F. Lang, Ssang-Goo Cho, E. Choi, 2007, The EMBO journal.

Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy

J. Chou, Lisa Zhang, Goo-Young Kim, 2017, Human molecular genetics.

Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Journal of Inherited Metabolic Disease.

PRMT1 negatively regulates activation‐induced cell death in macrophages by arginine methylation of GAPDH

E. Choi, Eunju Kim, Jun-Ho Cho, 2018, Experimental cell research.

Recent development and gene therapy for glycogen storage disease type Ia.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Liver research.

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia

E. Choi, J. Chou, Goo-Young Kim, 2017, PLoS genetics.

Liver-directed gene therapy for murine glycogen storage disease type Ib

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Human molecular genetics.

Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor‐developing stage

J. Chou, Jun-Ho Cho, Young Mok Lee, 2019, Journal of inherited metabolic disease.

Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.

J. Chou, Goo-Young Kim, D. Springer, 2015, Human molecular genetics.

Identification of a novel antiapoptotic protein that antagonizes ASK1 and CAD activities

S. Chi, Mi-Sung Kim, Ssang-Goo Cho, 2003, The Journal of cell biology.

CIB1 functions as a Ca2+-sensitive modulator of stress-induced signaling by targeting ASK1

J. Baik, Ssang-Goo Cho, E. Choi, 2009, Proceedings of the National Academy of Sciences.

Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI

D. A. Weinstein, Rong Wu, Jun-Ho Cho, 2019, Hepatology communications.

Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review

D. A. Weinstein, Jun-Ho Cho, Young Mok Lee, 2020, Journal of inherited metabolic disease.

An evolutionary approach to optimizing glucose‐6‐phosphatase‐α enzymatic activity for gene therapy of glycogen storage disease type Ia

J. Chou, I. Arnaoutova, Lisa Zhang, 2019, Journal of inherited metabolic disease.

Molecular biology and gene therapy for glycogen storage disease type Ib

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Journal of Inherited Metabolic Disease.

Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Biochemical and biophysical research communications.

Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Molecular genetics and metabolism.

Recent development and gene therapy for glycogen storage disease type Ia.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Liver research.